Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.
dc.contributor.author | Qekwana, Daniel Nenene![]() |
|
dc.contributor.author | Phophi, Lufuno![]() |
|
dc.contributor.author | Naidoo, Vinny![]() |
|
dc.contributor.author | Oguttu, James Wabwire![]() |
|
dc.contributor.author | Odoi, Agricola![]() |
|
dc.date.accessioned | 2019-03-06T13:00:50Z | |
dc.date.available | 2019-03-06T13:00:50Z | |
dc.date.issued | 2018-07-31 | |
dc.description.abstract | BACKGROUND : This study investigated the burden and predictors of canine E. coli urinary tract infections (UTI) and antimicrobial resistance among dogs presented at a veterinary teaching hospital in South Africa, 2007–2012. METHODS : The Cochran-Armitage trend test was used to investigate temporal trends while logistic regression models were used to investigate predictors (age, sex, breed, year) of E. coli infections and antimicrobial resistance (AMR). RESULTS : A total of 22.3% (168/755) of the urinary specimens tested positive for E. coli. A significant (p = 0.0004) decreasing temporal trend in the percentage of E. coli positive isolates was observed over the study period. There were high levels of AMR to penicillin-G (99%), clindamycin (100%), tylosine (95%), cephalothin (84%) but relatively low levels of resistance to enrofloxacin (16%), orbifloxacin (21%). Almost all (98%, 164/167) the isolates exhibited multidrug resistance (MDR), while only 11% (19/167) and 2% (4/167) exhibited extensive drug resistance (XDR) and pan-drug resistance (PDR), respectively. CONCLUSIONS : Although, the risk of E. coli UTI declined during the study period, the risk of AMR increased. The high levels of AMR and MDR as well as the presence of XDR and PDR is concerning as these have the potential of affecting prognosis of UTI treatments. | en_ZA |
dc.description.department | Paraclinical Sciences | en_ZA |
dc.description.librarian | am2019 | en_ZA |
dc.description.uri | https://bmcvetres.biomedcentral.com | en_ZA |
dc.identifier.citation | Qekwana, D.N., Phophi, L., Naidoo, V. et al. 2018, 'Antimicrobial resistance among Escherichia coli isolates from dogs presented with urinary tract infections at a veterinary teaching hospital in South Africa', BMC Veterinary Research, vol. 14, art. 228, pp. 1-6. | en_ZA |
dc.identifier.issn | 1746-6148 (online) | |
dc.identifier.other | 10.1186/s12917-018-1552-7 | |
dc.identifier.uri | http://hdl.handle.net/2263/68593 | |
dc.language.iso | en | en_ZA |
dc.publisher | BioMed Central | en_ZA |
dc.rights | © The Author(s). 2018. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). | en_ZA |
dc.subject | Urinary tract infection (UTI) | en_ZA |
dc.subject | Canine | en_ZA |
dc.subject | Multidrug-resistant (MDR) | en_ZA |
dc.subject | Extensive drug resistance | en_ZA |
dc.subject | Pan-drug resistance | en_ZA |
dc.subject | Veterinary medicine | en_ZA |
dc.subject | Teaching hospital | en_ZA |
dc.subject | South Africa (SA) | en_ZA |
dc.subject | Dogs | en_ZA |
dc.subject | Escherichia coli | en_ZA |
dc.subject | Cochran Armitage trend test | en_ZA |
dc.subject | Bacterium isolation | en_ZA |
dc.subject | Bacterium identification | en_ZA |
dc.subject | Bacterial load | en_ZA |
dc.subject | Antibiotic resistance | en_ZA |
dc.subject | Animal tissue | en_ZA |
dc.subject | Tylosin | en_ZA |
dc.subject | Penicillin G | en_ZA |
dc.subject | Orbifloxacin | en_ZA |
dc.subject | Enrofloxacin | en_ZA |
dc.subject | Clindamycin | en_ZA |
dc.subject | Cefalotin | en_ZA |
dc.subject | Antimicrobial resistance (AMR) | en_ZA |
dc.title | Antimicrobial resistance among Escherichia coli isolates from dogs presented with urinary tract infections at a veterinary teaching hospital in South Africa | en_ZA |
dc.type | Article | en_ZA |